Description

In order to help accelerate the time and reduce the cost between concept and cure, a number of new R&D initiatives are emerging.  These efforts aim to bring medicines to patients faster by facilitating collaboration to solve common challenges encountered during the discovery and development process.  This Super Session will focus on several of these recently-created public and private sector partnerships whose goal is to improve the productivity of the biomedical research ecosystem, and will explore how they may provide solutions with measurable impact for patients worldwide.

Session ID: 2023

myBIO Chatter

Speakers (5)

contact_6265 Christopher P. Austin, MD Director, National Center for Advancing Translational Sciences National Institutes of Health
contact_9757 Ronald A. DePinho, MD President The University of Texas MD Anderson Cancer Center
contact_9724 Dale M. Edgar, PhD Lilly Distinguished Research Fellow, LRL Eli Lilly and Company
contact_10144 Ann Meeker-O'Connell Acting Div Dir, Good Clinical Practice Compliance CDER, US Food and Drug Administration
contact_1189 Garry Neil, MD Partner & Head of R & D Apple Tree Partners

Moderators (1)

contact_4853 Margaret Anderson Executive Director FasterCures